The document discusses techniques for isolating and profiling microRNA (miRNA) expression in cancer patients and cell lines. It aims to identify novel miRNA biomarkers by comparing miRNA profiles between cancer and normal samples. Several cell lines are mentioned, including EBV-infected lymphoma cell lines, that could be used to assess changes in miRNA expression caused by viral infection and relate this to cancer pathogenesis.